DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Olux-E (Clobetasol Propionate Topical) - Published Studies

 
 



Olux-E Related Published Studies

Well-designed clinical trials related to Olux-E (Clobetasol Topical)

Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. [2014]

A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index. [2012]

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. [2011.09]

Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis. [2011.08]

Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]

A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. [2011.06]

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. [2011]

A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. [2011]

Excimer laser vs. clobetasol propionate 0.05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. [2010.10]

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. [2010.01]

Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations. [2010]

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. [2009.08.03]

Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.03]

Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. [2009.02]

Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. [2009.01.08]

Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. [2009.01]

Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis. [2009]

Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. [2008.12.26]

The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. [2008.05]

A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. [2008.02]

Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. [2007.01]

Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. [2007]

Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. [2006.11]

A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. [2006.10]

Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial. [2006.09]

Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial. [2006.02]

Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. [2006.01]

Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. [2005.08]

Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. [2005.05]

Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. [2005.02]

Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis. [2004.09]

Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis. [2004.07]

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. [2004.05]

Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis. [2003.11]

The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. [2003.07]

Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis. [2003.05]

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. [2003.05]

The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. [2003.05]

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. [2002.05]

Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment. [2002.03]

The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. [2001.11]

Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. [2001.09]

The therapeutic efficacy of mometasone furoate cream 0.1% applied once daily vs clobetasol propionate cream 0.05% applied twice daily in chronic eczema. [1999.05]

Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. [1999.01]

Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus. [1998.12]

Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. [1998.07]

Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis. [1998.02]

Topical clobetasol propionate compared with placebo in the treatment of unretractable foreskin. [1996.12]

Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate. [1996.02]

0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects. [1996]

The effects of topical indomethacin and clobetasol propionate on post-cryotherapy inflammation. [1995.05]

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. [1995.05]

Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. [1995]

Well-designed clinical trials possibly related to Olux-E (Clobetasol Topical)

[Bullous pemphigoid: a review]. [2011.03]

Applicability of an exaggerated forearm wash test for efficacy testing of two corticosteroids, tacrolimus and glycerol, in topical formulations against skin irritation induced by two different irritants. [2011.02]

Dermasilk briefs in vulvar lichen sclerosus: an adjuvant tool. [2011]

A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. [2009.07]

A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study. [2009.01.29]

Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. [2008.05]

Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis. [2007.09]

Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. [2007.06]

A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. [2007.03]

Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers. [2007]

Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study. [2006.11]

Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial. [2006.10]

Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. [2006.08]

Prediction of survival for patients with bullous pemphigoid: a prospective study. [2005.06]

Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. [2005.04]

Fluocinolone acetonide topical oil for scalp psoriasis. [2004.12]

Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. [2004.10]

Treatment of bullous pemphigoid. [2003.02]

An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion. [2003]

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. [2002.01.31]

VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis. [2000.02]

The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. [1998.12]

Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. [1998.10]

Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. [1998.09]

Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. [1998.08]

Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis. [1997]

Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study. [1996.09]

Other research related to Olux-E (Clobetasol Topical)

Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies. [2014]

The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test. [2011.09]

The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata. [2011.07.25]

A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis. [2011.02]

Efficacy of clobetasol spray: Factors beyond patient compliance. [2011.01.22]

Management of two cases of desquamative gingivitis with clobetasol and Calendula officinalis gel. [2010.12]

Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice. [2010.11]

HPA-suppressive effects of aqueous clobetasol propionate in the treatment of patients with oral lichen planus. [2010.09]

Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis. [2010.08.01]

Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice. [2010.04]

Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. [2010.03.19]

Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study. [2010.01]

Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. [2010]

Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot study. [2009.11]

Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. [2009.10]

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison. [2009.08]

Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study. [2009.06.22]

Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations. [2009]

Treatment of perniosis with oral pentoxyfylline in comparison with oral prednisolone plus topical clobetasol ointment in Iraqi patients. [2008.12]

Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. [2008.08]

Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. [2008.08]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017